Connected Drug Delivery Devices Market by Product, Technology, Therapy Area, Distribution Channel, End User - Global Forecast 2025-2030- Product Image

Sale

Connected Drug Delivery Devices Market by Product, Technology, Therapy Area, Distribution Channel, End User - Global Forecast 2025-2030

Report
184 Pages
October 2024
Region: Global
360iResearch™
ID: 6014742

UP TO €681EUR$697USD£569GBP OFF until Dec 31^st 2024

The Connected Drug Delivery Devices Market grew from USD 853.17 million in 2023 to USD 966.22 million in 2024. It is expected to continue growing at a CAGR of 14.45%, reaching USD 2.19 billion by 2030.

Connected Drug Delivery Devices are advanced medical devices designed to deliver medication to patients while enabling connectivity features like data transfer to healthcare systems for monitoring and analysis. The scope includes inhalers, injectors, infusion pumps, and wearable devices that integrate IoT technologies, enhancing patient adherence, personalized treatment, and data-driven healthcare decisions. These devices are essential in improving therapeutic outcomes and optimizing clinical workflows, offering applications in chronic disease management (e.g., diabetes, asthma) and personalized medicine. The end-use scope spans hospitals, clinics, home care settings, and research institutes.

Market growth is driven by burgeoning interest in digital health, the rising prevalence of chronic diseases, and increasing healthcare expenditure. Key factors include technological advancements in IoT, AI, and big data analytics, which enhance the functionality of these devices and facilitate real-time data monitoring and feedback. Opportunities arise from the growing demand for remote patient monitoring and telemedicine, which has surged post-COVID-19 and is likely to remain an integral healthcare component. Companies can capitalize on these trends by investing in user-friendly and secure devices that uphold data privacy.

However, challenges like high costs, stringent regulatory requirements, and concerns over data security and interoperability may hinder market expansion. The need to ensure robust cybersecurity and maintain standard protocols across platforms is critical. Areas of innovation include developing biodegradable materials for eco-friendly devices, integrating advanced AI algorithms for predictive analytics, and enhancing device-miniaturization technologies.

The market exhibits dynamic growth potential, particularly as governments and private sectors increasingly prioritize digital health integration. Collaboration with tech companies, focus on patient-centric design, and expansion into emerging markets (e.g., Asia-Pacific) present strategic avenues for business growth. In summary, embracing these opportunities while addressing limitations ensures a sustainable market trajectory, characterized by ongoing innovation and adaptation to evolving healthcare needs.

Understanding Market Dynamics in the Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising incidences of chronic diseases and disorders across the world
- Supportive regulatory approvals for connected drug delivery devices
- Supportive government policies to improve access to healthcare solutions for patients from diverse backgrounds
Market Restraints
- Complexities in the accuracy and efficacy of connected drug delivery devices
Market Opportunities
- Ongoing innovations to improve the safety and functionality of connected drug delivery devices
- Potential for the adoption of connected drug delivery devices for personalized medicine
Market Challenges
- Privacy concerns and data security issues associated with the usage of connected drug delivery devices

Exploring Porter’s Five Forces for the Connected Drug Delivery Devices Market

Porter’s Five Forces framework further strengthens the insights of the Connected Drug Delivery Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Connected Drug Delivery Devices Market

External macro-environmental factors deeply influence the performance of the Connected Drug Delivery Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Connected Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adherium Limited, AptarGroup, Inc., Becton, Dickinson, and Company, Cognita Labs LLC, Eli Lilly and Company, F. Hoffmann-La Roche AG, Findair Sp. z o. o., Gerresheimer AG, Medtronic PLC, Merck KGaA, Molex LLC, Novartis AG, Novo Nordisk A/S, OPKO Health, Inc., Otsuka America, Inc., Presspart Verwaltungs-GmbH, ResMed Inc., SHL Medical AG, Sulzer Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., West Pharmaceutical Services, Inc., Ypsomed Holding, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Connected Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Connected Injection Devices
- Smart Inhalers
- Smart Pills
Technology
- Bluetooth
- Near Field Communication
- Wi-Fi
Therapy Area
- Cardiovascular Diseases
- Diabetes
- Neurology
- Respiratory Diseases
Distribution Channel
- Hospitals & Clinical Pharmacies
- Online Platforms
- Pharmacies
End User
- Homecare Settings
- Hospitals & Clinics
- Research & Development Centers

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of chronic diseases and disorders across the world
5.1.1.2. Supportive regulatory approvals for connected drug delivery devices
5.1.1.3. Supportive government policies to improve access to healthcare solutions for patients from diverse backgrounds
5.1.2. Restraints
5.1.2.1. Complexities in the accuracy and efficacy of connected drug delivery devices
5.1.3. Opportunities
5.1.3.1. Ongoing innovations to improve the safety and functionality of connected drug delivery devices
5.1.3.2. Potential for the adoption of connected drug delivery devices for personalized medicine
5.1.4. Challenges
5.1.4.1. Privacy concerns and data security issues associated with the usage of connected drug delivery devices
5.2. Market Segmentation Analysis
5.2.1. Product: Emerging advancements and innovations in smart inhalers
5.2.2. Therapy Area: Need for connected drug delivery devices to facilitate real-time monitoring of respiratory diseases
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Connected Drug Delivery Devices Market, by Product

6.1. Introduction
6.2. Connected Injection Devices
6.3. Smart Inhalers
6.4. Smart Pills

7. Connected Drug Delivery Devices Market, by Technology

7.1. Introduction
7.2. Bluetooth
7.3. Near Field Communication
7.4. Wi-Fi

8. Connected Drug Delivery Devices Market, by Therapy Area

8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Diabetes
8.4. Neurology
8.5. Respiratory Diseases

9. Connected Drug Delivery Devices Market, by Distribution Channel

9.1. Introduction
9.2. Hospitals & Clinical Pharmacies
9.3. Online Platforms
9.4. Pharmacies

10. Connected Drug Delivery Devices Market, by End User

10.1. Introduction
10.2. Homecare Settings
10.3. Hospitals & Clinics
10.4. Research & Development Centers

11. Americas Connected Drug Delivery Devices Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Connected Drug Delivery Devices Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Connected Drug Delivery Devices Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Aptar Digital Health and SHL Medical Collaborate to Enhance Patient Experience with Self-Injectable Drug Delivery Devices
14.3.2. Adherium’s Smartinhaler Approved for Use with AstraZeneca Devices, Enhancing Connected Drug Delivery
14.3.3. New Partnership Launches Smart Devices for Tailored Asthma and COPD Care
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. CONNECTED DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. CONNECTED DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CONNECTED DRUG DELIVERY DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CONNECTED INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMART INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMART PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEAR FIELD COMMUNICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY WI-FI, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS & CLINICAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 47. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 74. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 79. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 89. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 119. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 135. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 140. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 145. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 155. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 165. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 180. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 185. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 190. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 210. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Connected Drug Delivery Devices Market, which are profiled in this report, include:

Abbott Laboratories
Adherium Limited
AptarGroup, Inc.
Becton, Dickinson, and Company
Cognita Labs LLC
Eli Lilly and Company
F. Hoffmann-La Roche AG
Findair Sp. z o. o.
Gerresheimer AG
Medtronic PLC
Merck KGaA
Molex LLC
Novartis AG
Novo Nordisk A/S
OPKO Health, Inc.
Otsuka America, Inc.
Presspart Verwaltungs-GmbH
ResMed Inc.
SHL Medical AG
Sulzer Ltd.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
West Pharmaceutical Services, Inc.
Ypsomed Holding
Zimmer Biomet Holdings, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 966.22 Million
Forecasted Market Value ( USD ) by 2030	$ 2190 Million
Compound Annual Growth Rate	14.4%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3466EUR$3,545USD£2,895GBP €3851EUR$3,939USD£3,217GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6132EUR$6,272USD£5,122GBP €6813EUR$6,969USD£5,691GBP

Understanding Market Dynamics in the Connected Drug Delivery Devices Market

Exploring Porter’s Five Forces for the Connected Drug Delivery Devices Market

Applying PESTLE Analysis to the Connected Drug Delivery Devices Market

Analyzing Market Share in the Connected Drug Delivery Devices Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Connected Drug Delivery Devices Market

Strategic Recommendations for Success in the Connected Drug Delivery Devices Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Connected Drug Delivery Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area and Geographical Region

Connected Drug Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Connected Drug Delivery Devices Market Report by Product, End User, Technology, and Region 2024-2032

Connected Drug Delivery Devices - Global Strategic Business Report